Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes
Estrogen synthesis from C19 precursors is catalyzed by aromatase cytochrome P450. Overexpression of aromatase through atypical promoter usage (use of promoter II) in adipose tissue contributes to breast cancer development and progression. One tumor-derived factor that appears to contribute to this process is prostaglandin E2 (PGE2). A factor that regulates aromatase expression downstream of PGE2 is liver receptor homolog-1 (LRH-1). In a study of factors that inhibit LRH-1, we have examined the ability of short heterodimer partner (SHP) to inhibit aromatase transcription mediated by LRH-1 in preadipocytes. RT-PCR analysis indicated that both LRH-1 and SHP are expressed in human preadipocytes. To assess the effect of SHP on aromatase transcription, a transient transfection system was established using 3T3-L1 preadipocytes. Expression of SHP completely inhibited activity of an aromatase promoter II reporter gene induced by LRH-1. The combined treatment of forskolin and phorbol ester (which mimic PGE2) as well as LRH-1, which maximally induced reporter gene expression (140-fold), was also completely inhibited by SHP. This effect of SHP was mediated by inhibition of LRH-1 transcriptional activity, as measured by activity of GAL4-LRH-1 fusion constructs, and by inhibition of LRH-1 binding to promoter II. We conclude that SHP is a potent inhibitor of aromatase transcription in preadipocytes. Modulation of SHP expression and/or activity in adipose tissue may therefore have significant effects on aromatase expression and estrogen production in breast adipose tissue.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2004 |
---|---|
Erschienen: |
2004 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Molecular endocrinology (Baltimore, Md.) - 18(2004), 1 vom: 01. Jan., Seite 252-9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kovacic, Agnes [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 21.09.2004 Date Revised 16.04.2009 published: Print-Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM143120794 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM143120794 | ||
003 | DE-627 | ||
005 | 20231223030124.0 | ||
007 | tu | ||
008 | 231223s2004 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0477.xml |
035 | |a (DE-627)NLM143120794 | ||
035 | |a (NLM)14593077 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kovacic, Agnes |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes |
264 | 1 | |c 2004 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 21.09.2004 | ||
500 | |a Date Revised 16.04.2009 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Estrogen synthesis from C19 precursors is catalyzed by aromatase cytochrome P450. Overexpression of aromatase through atypical promoter usage (use of promoter II) in adipose tissue contributes to breast cancer development and progression. One tumor-derived factor that appears to contribute to this process is prostaglandin E2 (PGE2). A factor that regulates aromatase expression downstream of PGE2 is liver receptor homolog-1 (LRH-1). In a study of factors that inhibit LRH-1, we have examined the ability of short heterodimer partner (SHP) to inhibit aromatase transcription mediated by LRH-1 in preadipocytes. RT-PCR analysis indicated that both LRH-1 and SHP are expressed in human preadipocytes. To assess the effect of SHP on aromatase transcription, a transient transfection system was established using 3T3-L1 preadipocytes. Expression of SHP completely inhibited activity of an aromatase promoter II reporter gene induced by LRH-1. The combined treatment of forskolin and phorbol ester (which mimic PGE2) as well as LRH-1, which maximally induced reporter gene expression (140-fold), was also completely inhibited by SHP. This effect of SHP was mediated by inhibition of LRH-1 transcriptional activity, as measured by activity of GAL4-LRH-1 fusion constructs, and by inhibition of LRH-1 binding to promoter II. We conclude that SHP is a potent inhibitor of aromatase transcription in preadipocytes. Modulation of SHP expression and/or activity in adipose tissue may therefore have significant effects on aromatase expression and estrogen production in breast adipose tissue | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Nr5a2 protein, mouse |2 NLM | |
650 | 7 | |a Receptors, Cytoplasmic and Nuclear |2 NLM | |
650 | 7 | |a nuclear receptor subfamily 0, group B, member 2 |2 NLM | |
650 | 7 | |a Aromatase |2 NLM | |
650 | 7 | |a EC 1.14.14.1 |2 NLM | |
650 | 7 | |a Cyclic AMP-Dependent Protein Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.11 |2 NLM | |
650 | 7 | |a Protein Kinase C |2 NLM | |
650 | 7 | |a EC 2.7.11.13 |2 NLM | |
700 | 1 | |a Speed, Caroline J |e verfasserin |4 aut | |
700 | 1 | |a Simpson, Evan R |e verfasserin |4 aut | |
700 | 1 | |a Clyne, Colin D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular endocrinology (Baltimore, Md.) |d 1989 |g 18(2004), 1 vom: 01. Jan., Seite 252-9 |w (DE-627)NLM01259444X |x 1944-9917 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2004 |g number:1 |g day:01 |g month:01 |g pages:252-9 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2004 |e 1 |b 01 |c 01 |h 252-9 |